In a chronic GvHD mouse model, treatment with MSC-derived EVs reduced the percentage of T follicular helper, germinal center B cells and macrophages as well as macrophage production of TGFβ and SMAD2 in the skin (63). This evidence concerns the gene SMAD2 and graft versus host disease.